See the source article by following the link below:
Peanut oral immunotherapy strongly desensitizes children and young adults to peanut allergy in a randomized, phase 2 trial. Results from a phase 3 trial are expected imminently.
Peanut oral immunotherapy strongly desensitizes children and young adults to peanut allergy in a randomized, phase 2 trial. Results from a phase 3 trial are expected imminently.
No comments:
Post a Comment